The West Hollywood Business License Commission is gearing up for a pivotal public hearing on Tuesday, June 11, 2024, that could spell trouble for one of the city’s pioneering cannabis dispensaries. MedMen WeHo, operating under the Cannabis Legacy Medical Business License No. CLM-000001, is facing the possibility of license revocation due to a string of violations of the West Hollywood Municipal Code.
Once a trailblazer in the medical marijuana industry, MedMen transitioned to adult-use cannabis sales in 2018 but has since found itself in hot water with city officials. The key issues leading to the potential license revocation include an unauthorized management agreement with Captor Retail Group, Inc., and failure to pay business taxes for several months.
City staff have issued multiple notices and citations to MedMen for these violations, but the dispensary continued to operate under the unapproved management agreement until it was terminated by the receiver in May 2024. The failure to comply with tax payments further exacerbated the situation, leading to the commission’s recommendation to revoke MedMen’s license.
The upcoming public hearing will be a critical juncture for MedMen as the commission deliberates on the fate of its Cannabis Legacy Medical Business License. The decision will be based on the grounds of violating city ordinances, failing to adhere to license conditions, and neglecting to pay taxes, all of which have put MedMen’s future in jeopardy. Stay tuned for updates on this developing story as the West Hollywood Business License Commission prepares to make a potentially game-changing decision.